BioVent secures $1.2 million in venture funding - MarketLine Financial Deals

BioVent secures $1.2 million in venture funding

BioVent secures $1.2 million in venture funding - MarketLine Financial Deals
BioVent secures $1.2 million in venture funding
Published Jan 13, 2010
2 pages — Published Jan 13, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

BioVent Ltd., an Israel-based developer of drugs to treat influenza, has secured $1.2 million in venture funding from Pontifax, Ltd., Biomedix Incubator, Ltd. and Roche Holding, Ltd.

  
Source:
Document ID
MA17765_100125
Country
Country
Ticker
BMDX=IL
Ticker
ROG=CH
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "BioVent secures $1.2 million in venture funding" Jan 13, 2010. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/BioVent-secures-1-2-million-in-venture-funding-2052-22472>
  
APA:
MarketLine Financial Deals. (2010). BioVent secures $1.2 million in venture funding Jan 13, 2010. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/BioVent-secures-1-2-million-in-venture-funding-2052-22472>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.